186 related articles for article (PubMed ID: 12121058)
1. MIXCON-LA: a precise, sensitive and specific aPTT-based assay for detection of lupus anticoagulant.
Lindhoff-Last E; Humpich M; Schmitt J; Rödiger S; Seifried E; Bauersachs R
Clin Appl Thromb Hemost; 2002 Apr; 8(2):163-7. PubMed ID: 12121058
[TBL] [Abstract][Full Text] [Related]
2. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
3. A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent.
Brancaccio V; Ames PR; Glynn J; Iannaccone L; Mackie IJ
Blood Coagul Fibrinolysis; 1997 Apr; 8(3):155-60. PubMed ID: 9167015
[TBL] [Abstract][Full Text] [Related]
4. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
[TBL] [Abstract][Full Text] [Related]
5. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
6. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
8. Magnesium-dependent activated partial thromboplastin time assay-Simple method for lupus anticoagulant detection.
Tokutake T; Ieko M; Naito S; Yoshida M; Baba H; Kobayashi H; Ishida F
Int J Lab Hematol; 2020 Feb; 42(1):46-51. PubMed ID: 31821738
[TBL] [Abstract][Full Text] [Related]
9. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
Denis-Magdelaine A; Flahault A; Verdy E
Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
12. [Clinical application of the activated partial thromboplastin time (APTT) with modified incubation time for the diagnosis of lupus anticoagulant (LA)].
Fardella P; Rustagi PK
Rev Med Chil; 2004 Apr; 132(4):407-12. PubMed ID: 15382511
[TBL] [Abstract][Full Text] [Related]
13. A quantitative, semi-automated and computer-assisted test for lupus anticoagulant.
Schjetlein R; Sletnes KE; Wisløff F
Thromb Res; 1993 Jan; 69(2):239-50. PubMed ID: 8446953
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
15. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
16. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
[TBL] [Abstract][Full Text] [Related]
17. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
Matsumoto T; Nogami K; Shima M
Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
[TBL] [Abstract][Full Text] [Related]
18. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Komiyama Y
Thromb Res; 2016 Jul; 143():53-7. PubMed ID: 27182981
[TBL] [Abstract][Full Text] [Related]
19. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
20. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
